Alzheimer's blood biomarkers and early detection

Jim Davis, Quest Diagnostics CEO, discusses how chronic disease management and consumer health testing are driving growth in the lab testing industry. He tells Katie Greifeld and Scarlet Fu on “The Close” that cancer testing accounts for about $1 billion of the company’s $11 billion portfolio.

See omnystudio.com/listener for privacy information.